Erech Finance Cahalacha

The company, founded in 1998, helps businesses and organizations reduce urban tax burdens, including property taxes, construction fees, development levies, improvement taxes, water and sewage charges, and other municipal taxes.

Insuline Medical Ltd. demonstrates early findings from a clinical feasibility study evaluating local injection-site treatments for long-acting insulin (insulin glargine). The company’s injection site treatment and stabilization technologies (ISTS) aim to enhance the effectiveness of subcutaneously delivered drugs. Initial data suggests potential improvements in insulin absorption or stability at the injection site.

Nov 2016BioSpaceNews article

Insuline Medical receives funding from Israel’s Chief Scientist to develop its injection site treatment and stabilization technology for use with long-acting insulin. The technology aims to improve insulin efficacy by addressing site-related issues during subcutaneous administration. This funding supports further research and clinical validation of the solution for diabetes management.

Mar 2016PR NewswireNews article

Insuline Medical enters a non-binding memorandum of understanding (MOU) to distribute its **InsuPad** device in **Brazil**. The agreement targets expansion into Latin America’s largest healthcare market. InsuPad is a wearable insulin delivery system designed for diabetes management.

Mar 2016PR NewswireNews article

Researchers at the Diabetes Unit of E. Wolfson Medical Center demonstrate that InsuPatch—a local heating device—enhances the pharmacokinetic and pharmacodynamic performance of insulin analogues. The study suggests the device may optimize insulin delivery efficiency by modulating absorption rates at the application site. Findings highlight potential clinical benefits for diabetes management through controlled thermal regulation of insulin patches.

Mar 2014Wiley Online LibraryNews article